Targeting adenosine for cancer immunotherapy

RD Leone, LA Emens - Journal for immunotherapy of cancer, 2018 - Springer
Immune checkpoint antagonists (CTLA-4 and PD-1/PD-L1) and CAR T-cell therapies
generate unparalleled durable responses in several cancers and have firmly established …

The role of neuroimmune signaling in alcoholism

FT Crews, CJ Lawrimore, TJ Walter, LG Coleman Jr - Neuropharmacology, 2017 - Elsevier
Alcohol consumption and stress increase brain levels of known innate immune signaling
molecules. Microglia, the innate immune cells of the brain, and neurons respond to alcohol …

[HTML][HTML] Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in …

AS Paller, WL Tom, MG Lebwohl, RL Blumenthal… - Journal of the American …, 2016 - Elsevier
Background Additional topical treatments for atopic dermatitis (AD) are needed that provide
relief while minimizing risks. Objective We sought to assess the efficacy and safety of …

NF-κB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer

Y Grinberg-Bleyer, H Oh, A Desrichard, DM Bhatt… - Cell, 2017 - cell.com
Regulatory T cells (Tregs) play a pivotal role in the inhibition of anti-tumor immune
responses. Understanding the mechanisms governing Treg homeostasis may therefore be …

[PDF][PDF] Alcoholic liver disease

RS O'shea, S Dasarathy, AJ McCullough… - …, 2010 - Wiley Online Library
These recommendations provide a data-supported approach. They are based on the
following:(1) formal review and analysis of the recently published world literature on the …

Apremilast mechanism of action and application to psoriasis and psoriatic arthritis

P Schafer - Biochemical pharmacology, 2012 - Elsevier
Psoriasis and psoriatic arthritis are common clinical conditions that negatively impact health-
related quality of life and are linked to serious medical comorbidities. Disease mechanisms …

[HTML][HTML] Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

PH Schafer, A Parton, L Capone, D Cedzik, H Brady… - Cellular signalling, 2014 - Elsevier
Apremilast, an oral small molecule inhibitor of phosphodiesterase 4 (PDE4), is in
development for chronic inflammatory disorders, and has shown efficacy in psoriasis …

Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development

WG Robichaux III, X Cheng - Physiological reviews, 2018 - journals.physiology.org
This review focuses on one family of the known cAMP receptors, the exchange proteins
directly activated by cAMP (EPACs), also known as the cAMP-regulated guanine nucleotide …

Keynote review: phosphodiesterase-4 as a therapeutic target

MD Houslay, P Schafer, KYJ Zhang - Drug discovery today, 2005 - Elsevier
Cyclic AMP (cAMP) is a key second messenger in all cells. It is compartmentalized within
cells and its levels are controlled, as a result of spatially discrete signaling cassettes …

[HTML][HTML] Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

LF Eichenfield, RS Call, DW Forsha, J Fowler Jr… - Journal of the American …, 2017 - Elsevier
Background Long-term topical treatment is often required for atopic dermatitis (AD), a
chronic inflammatory skin disease. Objective To assess the long-term safety results from a …